Evidence map›Paper›PMID 39299541›Full record

ArticleJournal of cardiac failure2025

Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart Failure.

Konstantinos Sideris, Mingyuan Zhang, Peter Wohlfahrt, Alfonso F Siu, Jincheng Shen, Spencer Carter, Christos P Kyriakopoulos, Iosif Taleb, Omar Wever-Pinzon, Kevin Shah and 14 more

Abstract read
In one paragraph

Article in Journal of cardiac failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Konstantinos SiderisDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Mingyuan ZhangDivision of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
Peter WohlfahrtDepartment of Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
Alfonso F SiuDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Jincheng ShenDivision of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
Spencer CarterDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Christos P KyriakopoulosDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Iosif TalebDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Omar Wever-PinzonDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Kevin ShahDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Craig H SelzmanDivision of Cardiothoracic Surgery, Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah.
Carlos Rodriguez-CorreaDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Chris KapeliosDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Lina BrinkerDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Rami AlharethiDivision of Cardiovascular Medicine, Department of Internal Medicine, Intermountain Medical Center Heart Institute, Salt Lake City, Utah.
Rachel HessDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Stavros G DrakosDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Benjamin A SteinbergDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
James C FangDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
Abdallah G KfouryDivision of Cardiovascular Medicine, Department of Internal Medicine, Intermountain Medical Center Heart Institute, Salt Lake City, Utah.
Vojtech MelenovskyDepartment of Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
Tom GreeneDivision of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
John A SpertusDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Missouri-Kansas City, Missouri.
Josef StehlikDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah. Electronic address: Josef.Stehlik@hsc.utah.edu.

Funding

CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
TRAINING IN CARDIOVASCULAR RESEARCHT32HL007576 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Stavros George Drakos, Robin M Shaw · 1985 to 2026
$10.6M
Optimizing Outcomes for Patients with Heart Failure and Atrial FibrillationK23HL143156 · NHLBI · UNIVERSITY OF UTAH · PI STEINBERG, BENJAMIN ADAM · 2018 to 2022
$951k
CSRD VA I01 CX000710NCATS NIH HHS UM1 TR004409NHLBI NIH HHS K23 HL143156NHLBI NIH HHS T32 HL007576
6 · The paper itself

Abstract

backgroundOptimal management of outpatients with heart failure (HF) requires serially updating the estimates of their risk for adverse clinical outcomes to guide treatment. Patient-reported outcomes (PROs) are becoming increasingly used in clinical care. The purpose of this study was to determine whether the inclusion of PROs can improve the risk prediction for HF hospitalization and death in ambulatory patients with HF. METHODS AND

resultsWe included consecutive patients with HF with reduced ejection fraction (HFrEF) and HF with preserved EF (HFpEF) seen in a HF clinic between 2015 and 2019 who completed PROs as part of routine care. Cox regression with a least absolute shrinkage and selection operator regularization and gradient boosting machine analyses were used to estimate risk for a combined outcome of HF hospitalization, heart transplant, left ventricular assist device implantation, or death. The performance of the prediction models was evaluated with the time-dependent concordance index (C

conclusionsPROs improve risk prediction in both HFrEF and HFpEF, independent of traditional clinical factors. Routine assessment of PROs and leveraging the comprehensive data in the electronic health record in routine clinical care could help more accurately assess risk and support the intensification of treatment in patients with HF.

Indexed as

Heart FailurePatient Reported Outcome MeasuresQuality of LifeAgedFemaleFollow-Up StudiesHospitalizationHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentStroke Volumegradient boosting machine modelheart failure with preserved ejection fractionheart failure with reduced ejection fractionoutcomesPatient-reported outcomesquality of life

Identifiers

PMID39299541
PMCPMC11913752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.